SkinVision Launches SkinVision Pro Platform for Medical Practices

SkinVision has launched SkinVision Pro, a platform that connects medical practices directly to the SkinVision Service, announced in a press release. The new service links AI powered skin health assessments to clinical workflows, allowing doctors to review structured patient data before consultations.

Patients can use the SkinVision Service to assess skin spots at home and receive a risk indication and recommendation. The results, including lesion images and reported symptoms, are shared with their medical practice through an integrated dashboard. SkinVision Pro is designed to fit into existing healthcare systems without adding administrative tasks.

The SkinVision Service is CE marked as a Class IIa medical device with validated accuracy of over 90 percent sensitivity and 89 percent specificity for skin cancer detection. Early data from Dutch primary care users in early 2026 showed that 80 percent of patients received low risk results and were reassured at home, while 24 percent of high risk users reported a confirmed skin cancer diagnosis.

Medical practices adopting SkinVision Pro receive access to a dashboard, onboarding materials, and support through the SkinVision Academy. The early adopter package includes digital and physical resources to help clinics integrate the service into daily operations.